These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15804239)

  • 41. Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
    Hummel HM; Brück W; Dreha-Kulaczewski S; Gärtner J; Wuerfel J
    Mult Scler; 2013 Sep; 19(10):1330-5. PubMed ID: 23828866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
    De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis.
    Sombekke MH; Wattjes MP; Balk LJ; Nielsen JM; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
    Neurology; 2013 Jan; 80(1):69-75. PubMed ID: 23243070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].
    Rovira A; Tintoré M; Alvarez-Cermeño JC; Izquierdo G; Prieto JM
    Neurologia; 2010 May; 25(4):248-65. PubMed ID: 20609303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.
    Wiebe S; Lee DH; Karlik SJ; Hopkins M; Vandervoort MK; Wong CJ; Hewitt L; Rice GP; Ebers GC; Noseworthy JH
    Ann Neurol; 1992 Nov; 32(5):643-50. PubMed ID: 1449244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis.
    Rot U; Ledinek AH; Jazbec SS
    Clin Neurol Neurosurg; 2008 Mar; 110(3):233-8. PubMed ID: 18093725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
    Kearney H; Yiannakas MC; Abdel-Aziz K; Wheeler-Kingshott CA; Altmann DR; Ciccarelli O; Miller DH
    J Magn Reson Imaging; 2014 Mar; 39(3):617-23. PubMed ID: 23633384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up of acute partial transverse myelitis.
    Bourre B; Zéphir H; Ongagna JC; Cordonnier C; Collongues N; Debette S; Fleury MC; Outteryck O; Hannequin D; Vermersch P; de Seze J
    Arch Neurol; 2012 Mar; 69(3):357-62. PubMed ID: 22410443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revised McDonald criteria for multiple sclerosis diagnostics in central Russia: sensitivity and specificity.
    Belova AN; Shalenkov IV; Shakurova DN; Boyko AN
    Mult Scler; 2014 Dec; 20(14):1896-9. PubMed ID: 25145690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
    Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
    Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
    Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sex-related differences in atrophy and lesion load in multiple sclerosis patients].
    Rojas JI; Patrucco L; Besada C; Funes J; Cristiano E
    Neurologia; 2013 Sep; 28(7):389-93. PubMed ID: 23246218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
    Pelayo R; Montalban X; Minoves T; Moncho D; Rio J; Nos C; Tur C; Castillo J; Horga A; Comabella M; Perkal H; Rovira A; Tintoré M
    Mult Scler; 2010 Jan; 16(1):55-61. PubMed ID: 19995838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
    Rot U; Mesec A
    Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria.
    Fangerau T; Schimrigk S; Haupts M; Kaeder M; Ahle G; Brune N; Klinkenberg K; Kotterba S; Möhring M; Sindern E;
    Acta Neurol Scand; 2004 Jun; 109(6):385-9. PubMed ID: 15147460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.
    Fazekas F; Offenbacher H; Fuchs S; Schmidt R; Niederkorn K; Horner S; Lechner H
    Neurology; 1988 Dec; 38(12):1822-5. PubMed ID: 3057397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial. Controlled High-Risk Subjects Avonex Multiple Sclerosis Prevention Study.
    Mult Scler; 2002 Aug; 8(4):330-8. PubMed ID: 12166504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.